Contents of the resolutions passed by the Extraordinary General Meeting of 22 October 2025 and information on the EGM's decision to refrain from considering one of the items on the planned agenda

Current Report No. 50/2025

Date of preparation: 22 October 2025

Subject: Contents of the resolutions passed by the Extraordinary General Meeting of 22 October 2025 and information on the EGM's decision to refrain from considering one of the items on the planned agenda

Legal basis: Article 56 (1) (2) of the Act on Offering - current and periodic information

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company") submits the content of the resolutions adopted by the Extraordinary General Meeting of the Company on 22 October 2025 (the "EGM") as an attachment.

At the same time, the Company announces that the Extraordinary General Meeting decided not to consider item 7 of the agenda, i.e. it decided not to adopt a resolution on granting options to members of the Company's Supervisory Board under the Second Incentive Scheme. The decision not to proceed was due to the fact that the EGM had previously adopted a resolution on the establishment of the Second Incentive Programme in the wording proposed by the Company's shareholder, which does not provide for the participation of members of the Supervisory Board in the programme. As a consequence, the consideration of the resolution on the granting of options became irrelevant.

Detailed legal basis:

§ 20 (1) (6) and (7) of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required by the laws of a non-member state